Interferon Alfa in Treating Children With HIV-Related Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 31, 1994

Primary Completion Date

July 31, 2002

Study Completion Date

September 30, 2005

Conditions
LeukemiaLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

recombinant interferon alfa

Trial Locations (10)

1211

Clinique de Pediatrie, Geneva

28801

Mission Saint Joseph's Health System, Asheville

67214

Via Christi Regional Medical Center, Wichita

70112

MBCCOP - LSU Health Sciences Center, New Orleans

75230

Medical City Dallas Hospital, Dallas

07601

Tomorrows Children's Institute, Hackensack

78236-5300

San Antonio Military Pediatric Cancer and Blood Disorders Center, Lackland Air Force Base

78284-7811

University of Texas Health Science Center at San Antonio, San Antonio

H3H 1P3

McGill University Health Center - Montreal Children's Hospital, Montreal

00936-5067

University of Puerto Rico School of Medicine Medical Sciences Campus, San Juan

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00002621 - Interferon Alfa in Treating Children With HIV-Related Cancer | Biotech Hunter | Biotech Hunter